#pharmanews
Russian Drone Attack Damages Indian Pharma Plant in Ukraine
A pharmaceutical facility owned by India’s Kusum Group was severely damaged in a Russian drone attack in Sumy, Ukraine. The strike reportedly killed one person and left several others injured. The main building of the plant was largely destroyed in the attack, with preliminary losses estimated at around ₹400 crore. Ukrainian President Volodymyr Zelensky expressed condolences over the loss of life and acknowledged the damage caused by the strike. The incident
Russian Drone Attack Damages Indian Pharma Plant in Ukraine
A pharmaceutical facility owned by India’s Kusum Group was severely damaged in a Russian drone attack in Sumy, Ukraine. The strike reportedly killed one person and left several others injured. The main building of the plant was largely destroyed in the attack, with preliminary losses estimated at around ₹400 crore. Ukrainian President Volodymyr Zelensky expressed condolences over the loss of life and acknowledged the damage caused by the strike. The incident
US eye drop recall expands to over 3 million bottles across major retailers
A California-based pharmaceutical company has expa
US eye drop recall expands to over 3 million bottles across major retailers
A California-based pharmaceutical company has expa
Eli Lilly becomes first health-care firm to briefly reach $1 trillion market value
Eli Lilly reached a historic milestone on Friday when it briefly surpassed a $1 trillion market capitalization, becoming the first health-care company in the world to enter a territory long dominated by technology giants. The company’s stock hovered near $1,048 per share during morning trading, touching the trillion-dollar threshold before pulling back slightly. It is only the second nontechnology business in the United States to reach this valuation, following Berkshire Hathaway’s climb
Eli Lilly becomes first health-care firm to briefly reach $1 trillion market value
Eli Lilly reached a historic milestone on Friday when it briefly surpassed a $1 trillion market capitalization, becoming the first health-care company in the world to enter a territory long dominated by technology giants. The company’s stock hovered near $1,048 per share during morning trading, touching the trillion-dollar threshold before pulling back slightly. It is only the second nontechnology business in the United States to reach this valuation, following Berkshire Hathaway’s climb









